相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial
Qi Mei et al.
Frontiers in Oncology (2022)
Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review
Douglas W. Blayney et al.
CANCER TREATMENT REVIEWS (2022)
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version) National Health Commission of the People's Republic of China
Binghe Xu et al.
CHINESE JOURNAL OF CANCER RESEARCH (2022)
Prophylaxis of febrile neutropenia with colony-stimulating factors: the first 25 years
John Edelsberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
Is PEGylated G-CSF superior to G-CSF in patients with breast cancer receiving chemotherapy? A systematic review and meta-analysis
Xiang Li et al.
SUPPORTIVE CARE IN CANCER (2020)
Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events
T. Christopher Bond et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2018)
Overall survival and risk of second malignancies with cancer chemotherapy and G-CSF support
G. H. Lyman et al.
ANNALS OF ONCOLOGY (2018)
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Paul Cornes et al.
ADVANCES IN THERAPY (2018)
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study
Jie Xie et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Pegylated granulocyte-colony stimulating factor versus non-pegylated granulocyte-colony stimulating factor for peripheral blood stem cell mobilization: A systematic review and meta-analysis
Jew W. Kuan et al.
JOURNAL OF CLINICAL APHERESIS (2017)
Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patients
Fan Zhang et al.
ONCOTARGET (2017)
The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis
Tran Do et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial
Norikazu Masuda et al.
SUPPORTIVE CARE IN CANCER (2015)
Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review
Alena M. Pfeil et al.
SUPPORTIVE CARE IN CANCER (2015)
Pharmacokinetics and Pharmacodynamics of Pegfilgrastim
Bing-Bing Yang et al.
CLINICAL PHARMACOKINETICS (2011)
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
NM Kuderer et al.
CANCER (2006)
分享论文
